Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss of $0.78/sh

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q4 EPS of ($0.78), versus ($0.17) reported last year.

For earnings history and earnings-related data on Aurinia Pharmaceuticals (AUPH) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Capitol Federal Financial names William Skrobacz Jr. as president
• UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order